🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/10/2020 | 101,03 | 103,59 | 100,05 | 103,17 | +2,15% | 3,50% | 269.000 |
| 30/09/2020 | 101,37 | 102,85 | 100,11 | 101,00 | -0,04% | 2,70% | 471.100 |
| 29/09/2020 | 101,82 | 101,82 | 100,09 | 101,04 | -0,46% | 1,70% | 179.600 |
| 28/09/2020 | 101,46 | 102,50 | 100,24 | 101,51 | +1,06% | 2,23% | 197.900 |
| 25/09/2020 | 99,44 | 102,00 | 99,07 | 100,45 | +0,55% | 2,95% | 262.700 |
| 24/09/2020 | 99,97 | 102,12 | 98,37 | 99,90 | -0,65% | 3,75% | 333.400 |
| 23/09/2020 | 102,24 | 103,31 | 100,51 | 100,55 | -1,70% | 2,74% | 218.600 |
| 22/09/2020 | 100,96 | 102,31 | 99,92 | 102,29 | +1,27% | 2,37% | 180.000 |
| 21/09/2020 | 104,43 | 104,76 | 100,54 | 101,01 | -4,43% | 4,04% | 354.600 |
| 18/09/2020 | 107,40 | 108,08 | 104,24 | 105,69 | -0,92% | 3,58% | 595.800 |
| 17/09/2020 | 104,72 | 106,93 | 104,22 | 106,67 | +0,56% | 2,59% | 203.800 |
| 16/09/2020 | 105,86 | 106,98 | 105,20 | 106,08 | +0,31% | 1,68% | 235.000 |
| 15/09/2020 | 105,47 | 107,33 | 105,01 | 105,75 | +0,87% | 2,20% | 243.900 |
| 14/09/2020 | 103,76 | 106,06 | 103,76 | 104,84 | +2,26% | 2,22% | 452.400 |
| 11/09/2020 | 102,98 | 103,80 | 101,52 | 102,52 | +0,08% | 2,21% | 243.000 |
| 10/09/2020 | 103,79 | 104,60 | 102,31 | 102,44 | -1,41% | 2,21% | 337.600 |
| 09/09/2020 | 102,90 | 104,45 | 102,00 | 103,90 | +1,16% | 2,38% | 243.500 |
| 08/09/2020 | 103,79 | 104,87 | 102,67 | 102,71 | -2,52% | 2,12% | 288.200 |
| 04/09/2020 | 105,49 | 106,37 | 102,84 | 105,37 | +0,77% | 3,35% | 217.100 |
| 03/09/2020 | 108,67 | 108,67 | 103,54 | 104,56 | -4,18% | 4,72% | 277.700 |
| 02/09/2020 | 105,13 | 109,48 | 105,13 | 109,12 | +3,42% | 4,14% | 386.100 |
| 01/09/2020 | 106,23 | 107,34 | 104,55 | 105,51 | -1,36% | 2,63% | 274.000 |
| 31/08/2020 | 105,83 | 107,55 | 105,06 | 106,96 | +0,87% | 2,35% | 261.100 |
| 28/08/2020 | 105,67 | 106,45 | 104,85 | 106,04 | +0,35% | 1,51% | 195.200 |
| 27/08/2020 | 105,46 | 106,18 | 104,00 | 105,67 | +0,60% | 2,07% | 320.000 |
| 26/08/2020 | 104,68 | 105,45 | 104,29 | 105,04 | -0,01% | 1,11% | 282.900 |
| 25/08/2020 | 105,83 | 107,35 | 103,58 | 105,05 | -0,82% | 3,56% | 339.400 |
| 24/08/2020 | 108,15 | 108,15 | 105,40 | 105,92 | -1,24% | 2,54% | 206.500 |
| 21/08/2020 | 106,83 | 107,56 | 105,86 | 107,25 | +0,59% | 1,59% | 291.000 |
| 20/08/2020 | 106,52 | 107,33 | 105,01 | 106,62 | -0,47% | 2,18% | 263.800 |